Umeå universitets logga

umu.sePublikationer
Ändra sökning
Länk till posten
Permanent länk

Direktlänk
Wang, Lixiao
Publikationer (10 of 32) Visa alla publikationer
Sajwan, R., Wang, L., Casar-Borota, O., Karakostis, K., Chen, S., Fåhraeus, R., . . . Gnanasundram, S. V. (2025). A cancer-associated TP53 synonymous mutation induces synthesis of the p53 isoform p53/47. British Journal of Cancer, 133, 970-975
Öppna denna publikation i ny flik eller fönster >>A cancer-associated TP53 synonymous mutation induces synthesis of the p53 isoform p53/47
Visa övriga...
2025 (Engelska)Ingår i: British Journal of Cancer, ISSN 0007-0920, E-ISSN 1532-1827, Vol. 133, s. 970-975Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Background: Synonymous mutations (SMs) change the mRNA nucleotide sequences without altering the corresponding amino acid sequence and are usually overlooked due to their perceived lack of influence on protein function. However, emerging reports suggest that SMs play a significant role in disease development and progression.

Methods: Whole exome sequencing, RNA-sequencing, and droplet digital PCR were performed to identify the SMs from the malignant glioma patients. MutaRNA was used to predict the effect of SMs on RNA structure in silico. SHAPE-MaP was performed to probe and assess the effect of SMs on RNA structure in-cellulo.

Results: Here, we report that a Cancer-Associated SM in TP53 codon valine 203 (CASM203) results in the induction of the alternative translation initiated p53 protein isoform, p47. In-cell high-throughput RNA structural mapping showed that CASM203 mimics the Protein Kinase RNA-Like ER Kinase (PERK)-mediated p53 mRNA secondary structure that induces p47 expression of during the unfolded protein response (UPR).

Conclusions: Overall, the single gain-of-function SM mimics the UPR-mediated p53 stress response, by generating RNA secondary structures akin to the PERK-mediated p53 mRNA structural switch. This illustrates the link between RNA structures and cellular biology and underscores the importance of SMs in cancer biology and their potential to further refine genetic diagnostics.

Ort, förlag, år, upplaga, sidor
Springer Nature, 2025
Nationell ämneskategori
Cancer och onkologi
Identifikatorer
urn:nbn:se:umu:diva-242537 (URN)10.1038/s41416-025-03127-w (DOI)001537797600001 ()40715694 (PubMedID)2-s2.0-105011718643 (Scopus ID)
Forskningsfinansiär
Cancerforskningsfonden i NorrlandCancerfonden, 180296Cancerfonden, 19 0073 Pj 01 HVetenskapsrådetCancerforskningsfonden i Norrland, AMP 22-1076Cancerforskningsfonden i Norrland, LP 24-2375Umeå universitet, 984461
Tillgänglig från: 2025-08-04 Skapad: 2025-08-04 Senast uppdaterad: 2025-11-26Bibliografiskt granskad
Gu, X., Coates, P. J., Wang, L., Gnanasundram, S. V., Sgaramella, N., Attaran, N., . . . Nylander, K. (2025). A unique plasma protein signature characterizes squamous cell carcinoma of the oral tongue in young adults. Journal of Oral Pathology & Medicine, 54(8), 706-714
Öppna denna publikation i ny flik eller fönster >>A unique plasma protein signature characterizes squamous cell carcinoma of the oral tongue in young adults
Visa övriga...
2025 (Engelska)Ingår i: Journal of Oral Pathology & Medicine, ISSN 0904-2512, E-ISSN 1600-0714, Vol. 54, nr 8, s. 706-714Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Background: The incidence of squamous cell carcinoma of the oral tongue (SCCOT) among young adults is increasing in several regions of the world. Age-dependent differences in the biology of SCCOT have been suspected.

Methods: We used the Olink Explore 3072 high-throughput platform to comprehensively quantify plasma proteins in 24 young (≤ 40 years of age) and 50 old (> 50 years of age) individuals. Eight young and 20 old individuals were diagnosed with SCCOT, four young and nine old individuals with SCC at other oral subsites (SCCOO), and the remaining 12 young and 21 old individuals were healthy controls. Dimension reduction analysis, differential expression analysis, and functional enrichment analysis were performed to characterize young patient-specific biological signatures.

Results: Plasma levels of 2923 proteins were obtained. Principal component analysis indicated age-related expression patterns. Comparing young patients to young controls/old patients/old controls, differential abundance analysis showed that increases in protein levels of Peroxiredoxin 2 (PRDX2) and C-C motif chemokine ligand 26 (CCL26) and a decrease in Kallikrein related peptidase 4 (KLK4) were young patient-specific. Reactome pathway enrichment analysis identified “Cellular response to chemical stress,” “Detoxification of reactive oxygen species” and “Cellular responses to stimuli” as the top altered pathways in young patients with SCCOT.

Conclusions: Abnormal cellular stress and aberrant immune regulation could thus be linked to cancer development in young patients. The unique plasma proteomic signature observed in young patients with SCCOT suggests that they constitute a specific group with distinct underlying pathophysiological processes.

Ort, förlag, år, upplaga, sidor
John Wiley & Sons, 2025
Nyckelord
age, CCL26, oral cancer, plasma, proteomics, ROS, tongue
Nationell ämneskategori
Cancer och onkologi
Identifikatorer
urn:nbn:se:umu:diva-243086 (URN)10.1111/jop.70020 (DOI)001545522600001 ()40765509 (PubMedID)2-s2.0-105012593202 (Scopus ID)
Forskningsfinansiär
Cancerfonden, 232775 Pj 01 HUmeå universitetRegion Västerbotten
Tillgänglig från: 2025-08-29 Skapad: 2025-08-29 Senast uppdaterad: 2025-09-22Bibliografiskt granskad
Wang, L., Sörensen, K., Coates, P. J., Gu, X., Sgaramella, N., Magan, M. B. & Nylander, K. (2025). Automated tumor-stroma ratio estimation for improved prognostic stratification of squamous cell carcinoma of the oral tongue. The journal of pathology. Clinical research, 11(4), Article ID e70036.
Öppna denna publikation i ny flik eller fönster >>Automated tumor-stroma ratio estimation for improved prognostic stratification of squamous cell carcinoma of the oral tongue
Visa övriga...
2025 (Engelska)Ingår i: The journal of pathology. Clinical research, ISSN 2056-4538, Vol. 11, nr 4, artikel-id e70036Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Squamous cell carcinoma of the oral tongue (SCCOT) represents an aggressive malignancy characterized by high metastatic potential and significant heterogeneity in its tumor microenvironment. The tumor-stroma ratio (TSR) has emerged as a prognostic biomarker, with higher stromal content frequently correlating with worse survival outcomes. Traditional approaches using the standard 50% TSR cutoff may not be optimal for SCCOT, and visual TSR estimation introduces variability during TSR region annotation. This study aimed to develop and validate a dedicated TSR estimation model for SCCOT by incorporating representative TSR regions from the invasive tumor front of whole slide images and to determine the optimal TSR threshold for prognostic stratification. Using hematoxylin and eosin-stained images from The Cancer Genome Atlas as a discovery cohort and whole slide images from Norrland's University Hospital Umea, Sweden (NUS) as a validation cohort, we developed a computational model to estimate TSR. The model demonstrated a high correlation with pathologist-based TSR estimation in both discovery (R = 0.848, p < 0.01) and validation (R = 0.783, p < 0.01) cohorts. The optimal 55% cutoff identified by the model improved prognostic accuracy over the traditional 50% threshold, with patients having high stroma within the tumor invasive front showing worse overall (log-rank p = 0.006) and disease-specific (log-rank p = 0.016) survival. Our computational TSR model for SCCOT demonstrates that automated TSR estimation enhances prognostic accuracy at an optimal cutoff of 55%, contributing to more precise risk stratification and potentially enabling personalized treatment strategies in SCCOT management.

Nyckelord
computational pathology, prognostic biomarker, SCCOT, tumor-stroma ratio, whole slide image
Nationell ämneskategori
Cancer och onkologi
Identifikatorer
urn:nbn:se:umu:diva-242527 (URN)10.1002/2056-4538.70036 (DOI)001530923700001 ()40673653 (PubMedID)2-s2.0-105011057673 (Scopus ID)
Forskningsfinansiär
Cancerfonden, 23 2775 Pj 01 HRegion Västerbotten
Tillgänglig från: 2025-08-04 Skapad: 2025-08-04 Senast uppdaterad: 2025-08-04Bibliografiskt granskad
Thermou, A., Daskalogianni, C., Wang, L., Malbert-Colas, L., Dinh, V.-T., Lavigne, M., . . . Habault, J. (2025). The codon context provides cis-acting immune evasion for the human papilloma virus (HPV) E6. RNA: A publication of the RNA Society, 31(12), 1735-1748
Öppna denna publikation i ny flik eller fönster >>The codon context provides cis-acting immune evasion for the human papilloma virus (HPV) E6
Visa övriga...
2025 (Engelska)Ingår i: RNA: A publication of the RNA Society, ISSN 1355-8382, E-ISSN 1469-9001, Vol. 31, nr 12, s. 1735-1748Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Human papilloma viruses (HPV) are linked to cancers, but how virus-carrying tumor cells express HPV-encoded antigens without attracting the immune system is still poorly understood. Here, we show how low- and high-risk HPV types equally exploit a cis-acting mechanism to limit the translation of the E6 mRNA, reducing the production of antigenic peptide substrates for the major histocompatibility class I (MHC-I) pathway. Introducing particular combinations of preferable codons throughout the HPV-16 E6 mRNA promotes mRNA translation and production of antigenic peptide substrates in mammalian cells but has minimal impact on E6 synthesis in Saccharomyces cerevisiae Using a gradual synonymous codon exchange, we identified a codon series with a significant effect on E6 translation rate. Unexpectedly, changing four nonpreferable codons to preferable codons in the wild-type sequence resulted in an ∼50% reduction in E6 expression. However, five additional changes to preferable codons further upstream shifted this inhibition to a strong induction of E6 expression, while they had no effect when introduced alone. These findings suggest a nuanced relationship between tRNA pools and translation rate, emphasizing how HPV uses codon usage to evade immune detection.

Ort, förlag, år, upplaga, sidor
Cold Spring Harbor Laboratory Press (CSHL), 2025
Nyckelord
codon usage, HPV E6, immune evasion
Nationell ämneskategori
Biokemi Molekylärbiologi
Identifikatorer
urn:nbn:se:umu:diva-246899 (URN)10.1261/rna.080390.125 (DOI)001615503500001 ()40957654 (PubMedID)2-s2.0-105022295221 (Scopus ID)
Tillgänglig från: 2025-12-03 Skapad: 2025-12-03 Senast uppdaterad: 2025-12-10Bibliografiskt granskad
Chen, S., Wang, L., Malbert-Colas, L., Karakostis, K., Olivares-Illana, V., Gnanasundram, S. V. & Fåhraeus, R. (2025). The p53 mRNA exhibits riboswitch-like features under DNA damage conditions. iScience, 28(10), Article ID 113555.
Öppna denna publikation i ny flik eller fönster >>The p53 mRNA exhibits riboswitch-like features under DNA damage conditions
Visa övriga...
2025 (Engelska)Ingår i: iScience, E-ISSN 2589-0042, Vol. 28, nr 10, artikel-id 113555Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

RNA riboswitch structures control prokaryotic gene expression in response to changes in the cellular environment, but how this concept has evolved in mammalian cells is yet little known. Here, we describe the riboswitch-like features of the p53 mRNA that controls p53 synthesis following DNA damage. The conserved BOX-I stem-loop in the 5′ coding sequence acts as an aptamer that controls the folding of a compact downstream MDM2-binding p53 mRNA structure. MDM2 brings the p53 mRNA to the ribosome and promotes p53 synthesis. High-throughput in-cell RNA structural probing and in vitro RNA-RNA and RNA-protein interactions show how the cancer-associated synonymous mutation in codon 22 (CASM22) of the BOX-I aptamer stabilizes the p53 mRNA structure and prevents the formation of the MDM2-binding platform. However, the CASM22 does not affect p53 mRNA folding during the unfolded protein response, demonstrating the specificity by which the CASM22 targets the p53 DNA damage response.

Ort, förlag, år, upplaga, sidor
Elsevier, 2025
Nyckelord
Molecular biology, Structural biology
Nationell ämneskategori
Biokemi Molekylärbiologi
Identifikatorer
urn:nbn:se:umu:diva-244854 (URN)10.1016/j.isci.2025.113555 (DOI)2-s2.0-105017073253 (Scopus ID)
Forskningsfinansiär
Cancerforskningsfonden i Norrland, LP 24–2351Cancerforskningsfonden i Norrland, LP 24–2375Cancerfonden, 22 2505 Pj 01HVetenskapsrådet, 2022-01080
Tillgänglig från: 2025-10-03 Skapad: 2025-10-03 Senast uppdaterad: 2025-10-03Bibliografiskt granskad
Zavadil, F., Henek, T., Habault, J., Chemali, R., Tovar-Fernandez, M. C., Daskalogianni, C., . . . Fåhraeus, R. (2025). Translation of bi-directional transcripts enhances MHC-I peptide diversity. Frontiers in Immunology, 16, Article ID 1554561.
Öppna denna publikation i ny flik eller fönster >>Translation of bi-directional transcripts enhances MHC-I peptide diversity
Visa övriga...
2025 (Engelska)Ingår i: Frontiers in Immunology, E-ISSN 1664-3224, Vol. 16, artikel-id 1554561Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Antisense transcripts play an important role in generating regulatory non-coding RNAs but whether these transcripts are also translated to generate functional peptides remains poorly understood. In this study, RNA sequencing and six-frame database generation were combined with mass spectrometry analysis of peptides isolated from polysomes to identify Nascent Pioneer Translation Products (Na-PTPs) originating from alternative reading frames of bi-directional transcripts. Two Na-PTP originating peptides derived from antisense strands stimulated CD8+ T cell proliferation when presented to peripheral blood mononuclear cells (PBMCs) from nine healthy donors. Importantly, an antigenic peptide derived from the reverse strand of two cDNA constructs was presented on MHC-I molecules and induced CD8+ T cell activation. The results demonstrate that three-frame translation of bi-directional transcripts generates antigenic peptide substrates for the immune system. This discovery holds significance for understanding the origin of self-discriminating peptide substrates for the major histocompatibility class I (MHC-I) pathway and for enhancing immune-based therapies against infected or transformed cells.

Ort, förlag, år, upplaga, sidor
Frontiers Media S.A., 2025
Nyckelord
bi-directional transcripts, bi-directional translation, MHC-I epitope, Pioneer Translation Products, reverse strand antigenic peptides
Nationell ämneskategori
Immunologi inom det medicinska området Immunologi
Identifikatorer
urn:nbn:se:umu:diva-237344 (URN)10.3389/fimmu.2025.1554561 (DOI)001455088300001 ()40165968 (PubMedID)2-s2.0-105001448358 (Scopus ID)
Tillgänglig från: 2025-04-23 Skapad: 2025-04-23 Senast uppdaterad: 2025-04-23Bibliografiskt granskad
Salehi, A. M., Wang, L., Gu, X., Coates, P. J., Norberg-Spaak, L., Sgaramella, N. & Nylander, K. (2024). Patients with oral tongue squamous cell carcinoma and co‑existing diabetes exhibit lower recurrence rates and improved survival: implications for treatment. Oncology Letters, 27(4), Article ID 142.
Öppna denna publikation i ny flik eller fönster >>Patients with oral tongue squamous cell carcinoma and co‑existing diabetes exhibit lower recurrence rates and improved survival: implications for treatment
Visa övriga...
2024 (Engelska)Ingår i: Oncology Letters, ISSN 1792-1074, E-ISSN 1792-1082, Vol. 27, nr 4, artikel-id 142Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Locoregional recurrences and distant metastases are major problems for patients with squamous cell carcinoma of the head and neck (SCCHN). Because SCCHN is a heterogeneous group of tumours with varying characteristics, the present study concentrated on the subgroup of squamous cell carcinoma of the oral tongue (SCCOT) to investigate the use of machine learning approaches to predict the risk of recurrence from routine clinical data available at diagnosis. The approach also identified the most important parameters that identify and classify recurrence risk. A total of 66 patients with SCCOT were included. Clinical data available at diagnosis were analysed using statistical analysis and machine learning approaches. Tumour recurrence was associated with T stage (P=0.001), radiological neck metastasis (P=0.010) and diabetes (P=0.003). A machine learning model based on the random forest algorithm and with attendant explainability was used. Whilst patients with diabetes were overrepresented in the SCCOT cohort, diabetics had lower recur‑ rence rates (P=0.015 after adjusting for age and other clinical features) and an improved 2‑year survival (P=0.025) compared with non‑diabetics. Clinical, radiological and histological data available at diagnosis were used to establish a prognostic model for patients with SCCOT. Using machine learning to predict recurrence produced a classification model with 71.2% accuracy. Notably, one of the findings of the feature importance rankings of the model was that diabetics exhibited less recur‑ rence and improved survival compared with non‑diabetics, even after accounting for the independent prognostic variables of tumour size and patient age at diagnosis. These data imply that the therapeutic manipulation of glucose levels used to treatdiabetes may be useful for patients with SCCOT regardless of their diabetic status. Further studies are warranted to investigatethe impact of diabetes in other SCCHN subtypes.

Ort, förlag, år, upplaga, sidor
Spandidos Publications, 2024
Nyckelord
diabetes, random forest, recurrence, squamous cell carcinoma, tongue
Nationell ämneskategori
Cancer och onkologi
Identifikatorer
urn:nbn:se:umu:diva-221662 (URN)10.3892/ol.2024.14275 (DOI)001168821200001 ()38385115 (PubMedID)2-s2.0-85185533910 (Scopus ID)
Forskningsfinansiär
Lions Cancerforskningsfond i NorrCancerfonden, 23 2775 Pj 01HRegion Västerbotten
Tillgänglig från: 2024-03-04 Skapad: 2024-03-04 Senast uppdaterad: 2025-04-24Bibliografiskt granskad
Gu, X., Salehi, A. M., Wang, L., Coates, P. J., Sgaramella, N. & Nylander, K. (2023). Early detection of squamous cell carcinoma of the oral tongue using multidimensional plasma protein analysis and interpretable machine learning. Journal of Oral Pathology & Medicine, 52(7), 637-643
Öppna denna publikation i ny flik eller fönster >>Early detection of squamous cell carcinoma of the oral tongue using multidimensional plasma protein analysis and interpretable machine learning
Visa övriga...
2023 (Engelska)Ingår i: Journal of Oral Pathology & Medicine, ISSN 0904-2512, E-ISSN 1600-0714, Vol. 52, nr 7, s. 637-643Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Background: Interpretable machine learning (ML) for early detection of cancer has the potential to improve risk assessment and early intervention.

Methods: Data from 261 proteins related to inflammation and/or tumor processes in 123 blood samples collected from healthy persons, but of whom a sub-group later developed squamous cell carcinoma of the oral tongue (SCCOT), were analyzed. Samples from people who developed SCCOT within less than 5 years were classified as tumor-to-be and all other samples as tumor-free. The optimal ML algorithm for feature selection was identified and feature importance computed by the SHapley Additive exPlanations (SHAP) method. Five popular ML algorithms (AdaBoost, Artificial neural networks [ANNs], Decision Tree [DT], eXtreme Gradient Boosting [XGBoost], and Support Vector Machine [SVM]) were applied to establish prediction models, and decisions of the optimal models were interpreted by SHAP.

Results: Using the 22 selected features, the SVM prediction model showed the best performance (sensitivity = 0.867, specificity = 0.859, balanced accuracy = 0.863, area under the receiver operating characteristic curve [ROC-AUC] = 0.924). SHAP analysis revealed that the 22 features rendered varying person-specific impacts on model decision and the top three contributors to prediction were Interleukin 10 (IL10), TNF Receptor Associated Factor 2 (TRAF2), and Kallikrein Related Peptidase 12 (KLK12).

Conclusion: Using multidimensional plasma protein analysis and interpretable ML, we outline a systematic approach for early detection of SCCOT before the appearance of clinical signs.

Ort, förlag, år, upplaga, sidor
John Wiley & Sons, 2023
Nyckelord
machine learning, interpretable model, SHAP, SCCOT, PLASMA PROTEIN
Nationell ämneskategori
Cancer och onkologi
Forskningsämne
genetik
Identifikatorer
urn:nbn:se:umu:diva-208270 (URN)10.1111/jop.13461 (DOI)001026127400001 ()37428440 (PubMedID)2-s2.0-85164698201 (Scopus ID)
Forskningsfinansiär
Cancerfonden, 20 0754 PjF 01HRegion VästerbottenUmeå universitet
Anmärkning

Originally included in thesis in manuscript form. 

Tillgänglig från: 2023-05-15 Skapad: 2023-05-15 Senast uppdaterad: 2025-04-24Bibliografiskt granskad
Gu, X., Wang, L., Coates, P. J., Gnanasundram, S. V., Sgaramella, N., Sörlin, J., . . . Nylander, K. (2023). Evidence for etiologic field changes in tongue distant from tumor in patients with squamous cell carcinoma of the oral tongue. Journal of Pathology, 259(1), 93-102
Öppna denna publikation i ny flik eller fönster >>Evidence for etiologic field changes in tongue distant from tumor in patients with squamous cell carcinoma of the oral tongue
Visa övriga...
2023 (Engelska)Ingår i: Journal of Pathology, ISSN 0022-3417, E-ISSN 1096-9896, Vol. 259, nr 1, s. 93-102Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Oral cancer is a paradigm of Slaughter's concept of field cancerization, where tumors are thought to originate within an area of cells containing genetic alterations that predispose to cancer development. The field size is unclear but may represent a large area of tissue, and the origin of mutations is also unclear. Here, we analyzed whole exome and transcriptome features in contralateral tumor-distal tongue (i.e. distant from the tumor, not tumor-adjacent) and corresponding tumor tissues of 15 patients with squamous cell carcinoma of the oral tongue. The number of point mutations ranged from 41 to 237 in tumors and from one to 78 in tumor-distal samples. Tumor-distal samples showed mainly clock-like (associated with aging) or tobacco smoking mutational signatures. Tumors additionally showed mutations that associate with cytidine deaminase AID/APOBEC enzyme activities or a UV-like signature. Importantly, no point mutations were shared between a tumor and the matched tumor-distal sample in any patient. TP53 was the most frequently mutated gene in tumors (67%), whereas a TP53 mutation was detected in only one tumor-distal sample, and this mutation was not shared with the matched tumor. Arm-level copy number variation (CNV) was found in 12 tumors, with loss of chromosome (Chr) 8p or gain of 8q being the most frequent events. Two tumor-distal samples showed a gain of Chr8, which was associated with increased expression of Chr8-located genes in these samples, although gene ontology did not show a role for these genes in oncogenic processes. In situ hybridization revealed a mixed pattern of Chr8 gain and neutral copy number in both tumor cells and adjacent nontumor epithelium in one patient. We conclude that distant field cancerization exists but does not present as tumor-related mutational events. The data are compatible with etiologic field effects, rather than classical monoclonal field cancerization theory. © 2022 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Ort, förlag, år, upplaga, sidor
John Wiley & Sons, 2023
Nyckelord
chromosome 8, CNV, field cancerization, SCCOT, SNV
Nationell ämneskategori
Cancer och onkologi
Identifikatorer
urn:nbn:se:umu:diva-201951 (URN)10.1002/path.6025 (DOI)000897573600001 ()36314576 (PubMedID)2-s2.0-85143907179 (Scopus ID)
Forskningsfinansiär
Cancerfonden, 20 0754 PjF 01HUmeå universitetRegion Västerbotten
Tillgänglig från: 2022-12-28 Skapad: 2022-12-28 Senast uppdaterad: 2024-04-24Bibliografiskt granskad
Fusée, L., Salomao, N., Ponnuswamy, A., Wang, L., López, I., Chen, S., . . . Fåhraeus, R. (2023). The p53 endoplasmic reticulum stress-response pathway evolved in humans but not in mice via PERK-regulated p53 mRNA structures. Cell Death and Differentiation, 30, 1072-1081
Öppna denna publikation i ny flik eller fönster >>The p53 endoplasmic reticulum stress-response pathway evolved in humans but not in mice via PERK-regulated p53 mRNA structures
Visa övriga...
2023 (Engelska)Ingår i: Cell Death and Differentiation, ISSN 1350-9047, E-ISSN 1476-5403, Vol. 30, s. 1072-1081Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Cellular stress conditions activate p53-dependent pathways to counteract the inflicted damage. To achieve the required functional diversity, p53 is subjected to numerous post-translational modifications and the expression of isoforms. Little is yet known how p53 has evolved to respond to different stress pathways. The p53 isoform p53/47 (p47 or ΔNp53) is linked to aging and neural degeneration and is expressed in human cells via an alternative cap-independent translation initiation from the 2nd in-frame AUG at codon 40 (+118) during endoplasmic reticulum (ER) stress. Despite an AUG codon in the same location, the mouse p53 mRNA does not express the corresponding isoform in either human or mouse-derived cells. High-throughput in-cell RNA structure probing shows that p47 expression is attributed to PERK kinase-dependent structural alterations in the human p53 mRNA, independently of eIF2α. These structural changes do not take place in murine p53 mRNA. Surprisingly, PERK response elements required for the p47 expression are located downstream of the 2nd AUG. The data show that the human p53 mRNA has evolved to respond to PERK-mediated regulation of mRNA structures in order to control p47 expression. The findings highlight how p53 mRNA co-evolved with the function of the encoded protein to specify p53-activities under different cellular conditions.

Ort, förlag, år, upplaga, sidor
Springer Nature, 2023
Nationell ämneskategori
Cell- och molekylärbiologi Biokemi Molekylärbiologi
Identifikatorer
urn:nbn:se:umu:diva-205356 (URN)10.1038/s41418-023-01127-y (DOI)000937073800002 ()36813920 (PubMedID)2-s2.0-85148504831 (Scopus ID)
Forskningsfinansiär
Cancerforskningsfonden i Norrland, LP 21-2270Europeiska regionala utvecklingsfonden (ERUF), CZ.02.1.01/0.0/0.0/16_019/0000868Cancerfonden, 180296Cancerfonden, 19 0073 Pj 01 HVetenskapsrådetKempestiftelserna, SMK1864Cancerforskningsfonden i Norrland, AMP 22-1076
Tillgänglig från: 2023-03-30 Skapad: 2023-03-30 Senast uppdaterad: 2025-02-20Bibliografiskt granskad
Organisationer

Sök vidare i DiVA

Visa alla publikationer